Risk factors associated with multidrug-resistant tuberculosis in Espírito Santo, Brazil

Authors

  • Geisa Fregona Universidade Federal do Espírito Santo; Hospital Universitário Cassiano Antônio de Moraes
  • Lorrayne Belique Cosme Universidade Federal do Espírito Santo
  • Cláudia Maria Marques Moreira Universidade Federal do Espírito Santo
  • José Luis Bussular Prefeitura Municipal de Vila Velha; Laboratório de Micobacteriologia
  • Valdério do Valle Dettoni Universidade Federal do Espírito Santo; Centro de Ciências da Saúde; Departamento de Clínica Médica
  • Margareth Pretti Dalcolmo Fundação Oswaldo Cruz; Escola Nacional de Saúde Pública Sérgio Arouca; Centro de Referência Professor Hélio Fraga
  • Eliana Zandonade Universidade Federal do Espírito Santo; Departamento de Estatística
  • Ethel Leonor Noia Maciel Universidade Federal do Espírito Santo; Departamento de Enfermagem

DOI:

https://doi.org/10.1590/s1518-8787.2017051006688

Keywords:

Tuberculosis, Multidrug-Resistant, epidemiology, Drug Resistance, Multiple, Bacterial, Recurrence, Risk Factors, Socioeconomic Factors

Abstract

OBJECTIVE To analyze the prevalence and factors associated with multidrug-resistant tuberculosis in Espírito Santo, Brazil. METHODS This is a cross-sectional study of cases of tuberculosis tested for first-line drugs (isoniazid, rifampicin, pyrazinamide, ethambutol, and streptomycin) in Espírito Santo between 2002 and 2012. We have used laboratory data and registration of cases of tuberculosis – from the Sistema Nacional de Agravos de Notificação and Sistema para Tratamentos Especiais de Tuberculose. Individuals have been classified as resistant and non-resistant and compared in relation to the sociodemographic, clinical, and epidemiological variables. Some variables have been included in a logistic regression model to establish the factors associated with resistance. RESULTS In the study period, 1,669 individuals underwent anti-tuberculosis drug susceptibility testing. Of these individuals, 10.6% showed resistance to any anti-tuberculosis drug. The rate of multidrug resistance observed, that is, to rifampicin and isoniazid, has been 5%. After multiple analysis, we have identified as independent factors associated with resistant tuberculosis: history of previous treatment of tuberculosis [recurrence (OR = 7.72; 95%CI 4.24–14.05) and re-entry after abandonment (OR = 3.91; 95%CI 1.81–8.43)], smoking (OR = 3.93; 95%CI 1.98–7.79), and positive culture for Mycobacterium tuberculosis at the time of notification of the case (OR = 3.22; 95%CI 1.15–8.99). CONCLUSIONS The partnership between tuberculosis control programs and health teams working in the network of Primary Health Care needs to be strengthened. This would allow the identification and monitoring of individuals with a history of previous treatment of tuberculosis and smoking. Moreover, the expansion of the offer of the culture of tuberculosis and anti-tuberculosis drug susceptibility testing would provide greater diagnostic capacity for the resistant types in Espírito Santo.

Published

2017-01-01

Issue

Section

Original Articles

How to Cite

Fregona, G., Cosme, L. B., Moreira, C. M. M., Bussular, J. L., Dettoni, V. do V., Dalcolmo, M. P., Zandonade, E., & Maciel, E. L. N. (2017). Risk factors associated with multidrug-resistant tuberculosis in Espírito Santo, Brazil. Revista De Saúde Pública, 51, 41. https://doi.org/10.1590/s1518-8787.2017051006688